Longshot , imo caution is advised until full year results delivered and market guidance on earnings going forward given
EBITDA of $5.3m does not equal profit
NPAT for 2017 ????
Market cap at around $40m very high p/e
Focusing on performance marketing in Aust, NZ and U.K.
Will this deliver global earnings growth ??
imo,
To much excitement around here for an update out with little details just before full year results
Excitement seems to be fast disappearing late afternoon
- Forums
- ASX - By Stock
- IMS
- Ann: Market Update
Ann: Market Update, page-26
-
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online